These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 11795118)

  • 21. Postprandial glycemia and cardiovascular disease in diabetes mellitus.
    Wajchenberg BL
    Arq Bras Endocrinol Metabol; 2007 Mar; 51(2):212-21. PubMed ID: 17505628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of HbA1c, followed from onset of type 1 diabetes, on the development of severe retinopathy and nephropathy: the VISS Study (Vascular Diabetic Complications in Southeast Sweden).
    Nordwall M; Abrahamsson M; Dhir M; Fredrikson M; Ludvigsson J; Arnqvist HJ
    Diabetes Care; 2015 Feb; 38(2):308-15. PubMed ID: 25510400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Epidemiology of cardio-vascular complications of diabetes].
    Grimaldi A; Heurtier A
    Diabetes Metab; 1999 Jun; 25 Suppl 3():12-20. PubMed ID: 10421988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Catalase/superoxide dismutase (SOD) and catalase/paraoxonase (PON) ratios may implicate poor glycemic control.
    Sözmen EY; Sözmen B; Delen Y; Onat T
    Arch Med Res; 2001; 32(4):283-7. PubMed ID: 11440784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hyperglycemia and cardiovascular risk].
    Bianchi C; Del Prato S; Miccoli R
    G Ital Cardiol (Rome); 2010 Sep; 11(9):654-9. PubMed ID: 21348180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coronary artery calcium: a clue to the enigma of tight glycemic control and cardiovascular disease?
    Bertoni AG; Kitzman DW
    Diabetes; 2009 Nov; 58(11):2448-9. PubMed ID: 19875621
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of glycaemic control on cardiovascular disease in diabetic American Indians: the Strong Heart Study.
    Lu WQ; Resnick HE; Jablonski KA; Jain AK; Jones KL; Robbins DC; Howard BV
    Diabet Med; 2004 Apr; 21(4):311-7. PubMed ID: 15049931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glycemic variability and diabetes retinopathy: a missing link.
    Hsu CR; Chen YT; Sheu WH
    J Diabetes Complications; 2015 Mar; 29(2):302-6. PubMed ID: 25534877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of postprandial hyperglycemia at clinic visits on the incidence of retinopathy in patients with type 2 diabetes: An analysis using real-world long-term follow-up data.
    Takao T; Takahashi K; Yoshida Y; Kushiyama A; Onishi Y; Tahara T; Shimmei A; Kikuchi T; Suka M; Yanagisawa H; Iwamoto Y; Kasuga M
    J Diabetes Investig; 2020 Jul; 11(4):930-937. PubMed ID: 31811705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relation of glycemic control to diabetic complications and health outcomes.
    Klein R; Klein BE
    Diabetes Care; 1998 Dec; 21 Suppl 3():C39-43. PubMed ID: 9850488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glycaemic control and development of retinopathy in type 2 diabetes mellitus: a longitudinal study.
    Guillausseau PJ; Massin P; Charles MA; Allaguy H; Güvenli Z; Virally M; Tielmans D; Assayag M; Warnet A; Lubetzki J
    Diabet Med; 1998 Feb; 15(2):151-5. PubMed ID: 9507917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glycemic control and CAD risk: a heretical thought.
    Orchard TJ
    Diabetes Care; 1999 Jul; 22(7):1220. PubMed ID: 10388997
    [No Abstract]   [Full Text] [Related]  

  • 33. [Glycosylated hemoglobin as a prognostic index of the appearance of vascular complications in diabetic patients].
    Ezcurra Ferrer EJ; Licea Puig M; Díaz Díaz O
    Rev Clin Esp; 1990; 187(3):121-4. PubMed ID: 2284483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severity of background retinopathy in type 1 diabetes increases with the level of long-term glycated haemoglobin.
    Kullberg CE; Finnström K; Arnqvist HJ
    Acta Ophthalmol (Copenh); 1994 Apr; 72(2):181-8. PubMed ID: 8079623
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of the relationships of the glucose tolerance test and the glycated haemoglobin assay with diabetic vascular disease in the community. The Islington Diabetes Survey.
    Jackson CA; Yudkin JS; Forrest RD
    Diabetes Res Clin Pract; 1992 Aug; 17(2):111-23. PubMed ID: 1425145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiology patient pages. Cardiovascular disease in the diabetic patient.
    Goldfine AB; Goldfine HL
    Circulation; 2003 Jan; 107(2):e14-6. PubMed ID: 12538441
    [No Abstract]   [Full Text] [Related]  

  • 37. Verification of Kumamoto Declaration 2013 and Glycemic Targets for Elderly Patients with Diabetes in Japan for prevention of diabetic complications: A retrospective longitudinal study using outpatient clinical data.
    Nakanishi S; Hirukawa H; Shimoda M; Tatsumi F; Kohara K; Obata A; Kimura T; Okauchi S; Kinoshita T; Sanada J; Fushimi Y; Nishioka M; Mizoguchi A; Mune T; Kaku K; Kaneto H
    J Diabetes Investig; 2019 Mar; 10(2):290-301. PubMed ID: 30099853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Blood glucose control and prevention of microangiopathy and macroangiopathy in type 2 diabetes].
    Scheen AJ; Paquot N
    Rev Med Liege; 2003 May; 58(5):265-70. PubMed ID: 12940112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are individuals with diabetes seeing better?: a long-term epidemiological perspective.
    Klein R; Klein BE
    Diabetes; 2010 Aug; 59(8):1853-60. PubMed ID: 20668290
    [No Abstract]   [Full Text] [Related]  

  • 40. [Near-norm blood sugar regulation in diabetes. Myocardial infarct rate halved].
    MMW Fortschr Med; 2005 Sep; 147(35-36):4-5. PubMed ID: 16180560
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.